Evan M. Hersh, M.D.

Professor, Medicine

Assistant Director, Hematology/Oncology Section

Cancer Center 1957
P.O. Box 245024
Tucson AZ 85724-5024

Phone: (520)626-2250 or (520)626-6372
E-mail: hersh@azcc.arizona.edu    

EDUCATION:

-Columbia University, 1960 (M.D.)

-St. Lukes Hospital, 1960-1961 (Internship)

-Stanford University, 1961-1962, 1965-1966 (Residency)

-National Cancer Institute, 1962-1965

 
HONORS/AWARDS:

-Top 300 Most Cited Contemporary Scientists, 1981

-Citation Superstars ‘65-’78, 1990

-Citation Superstars ‘73-’84, 1990

-J. A. Gottlieb Award from M.D. Anderson Cancer Center, 1992

-Best Doctors in America, 1997

RESEARCH ACTIVITIES:

Immunological characteristics of cancer and the cellular immune response to malignant cells for new immunotherapy and chemotherapy for cancer; in vitro test systems and models for new AIDS therapy; human IgG monoclonal antibodies to cancer antigens and HIV; conduct clinical trials of anticancer and anti-AIDS drugs; immunotherapy of malignant melanoma by direct gene transfer; head of multidisciplinary gene therapy program.  

SELECTED PUBLICATIONS:

Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM, Haluska FG; Oblimersen Melanoma Study Group. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol. 24(29):4738-45, 2006.

Cranmer LD, Trevor KT, Bandlamuri S, Hersh EM. Rodent models of brain metastasis in melanoma. Melanoma Res. 2005 Oct;15(5):325-56, 2005.

Whitehead RP, Moon J, McCachren SS, Hersh EM, Samlowski WE, Beck JT, Tchekmedyian NS, Sondak VK; Southwest Oncology Group. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Cancer. 100(8):1699-704, 2004.

Trevor KT, Cover C, Ruiz YW, Akporiaye ET, Hersh EM, Landais D, Taylor RR, King AD, Walters RE. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application. Cancer Immunol Immunother. 53(8):705-14, 2004.

Last updated:  3/1/2007